Survival of cancer patients in France:: A population-based study from the Association of the French Cancer Registries (FRANCIM)

被引:131
作者
Bossard, N.
Velten, M.
Remontet, L.
Belot, A.
Maarouf, N.
Bouvier, A. M.
Guizard, A. V.
Tretarre, B.
Launoy, G.
Colonna, M.
Danzon, A.
Molinie, F.
Troussard, X.
Bourdon-Raverdy, N.
Carli, P. M.
Jaffre, A.
Bessaguet, C.
Sauleau, E.
Schvartz, C.
Arveux, P.
Maynadie, M.
Grosclaude, P.
Esteve, J.
Faivre, J.
机构
[1] Hospices Civils Lyon, Serv Biostat, F-69003 Lyon, France
[2] CNRS, F-69100 Villeurbanne, France
[3] Univ Lyon 1, UMR 5558, Lab Biostat Sante, F-69100 Villeurbanne, France
[4] Reseau FRANCIM, Fac Med, Toulouse, France
[5] Inst Veille Sanitaire, Dept Malad Chron & Traumatismes, St Maurice, France
关键词
neoplasms; registries; survival; survival analysis; proportional hazards models; statistical models; mortality;
D O I
10.1016/j.ejca.2006.07.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
We present the main results of the first population-based cancers survival study gathering all French registry data. Survival data on 205,562 cancer cases diagnosed between 01/01/ 1989 and 31/12/1997 were analysed. Relative survival was estimated using an excess rate model. The evolution of the excess mortality rate over the follow-up period was graphed. The analysis emphasised the effect of age at diagnosis and its variation with time after diagnosis. For breast and prostate cancers, the age-standardised five-year relative survivals were 84% and 77%, respectively. The corresponding results in men and women were 56% versus 58% for colorectal cancer and 12% versus 16% for lung cancer. For some cancer sites, the excess mortality rate decreased to low values by five years after diagnosis. For most cancer sites, age at diagnosis was a negative prognostic factor but this effect was often limited to the first year after diagnosis. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:149 / 160
页数:12
相关论文
共 27 条
[1]
Akaike H, 1973, 2 INT S INFORM THEOR, P199, DOI 10.1007/978-1-4612-1694-0
[2]
Use of period analysis for providing more up-to-date estimates of long-term survival rates:: empirical evaluation among 370 000 cancer patients in Finland [J].
Brenner, H ;
Söderman, B ;
Hakulinen, T .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (02) :456-462
[3]
CAPAOCACCIA R, 2003, ANN ONCOL, V14, P14
[4]
Coleman M, 1999, SERIES SMPS, V61
[5]
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century [J].
Coleman, M. P. ;
Gatta, G. ;
Verdecchia, A. ;
Esteve, J. ;
Sant, M. ;
Storm, H. ;
Allemani, C. ;
Ciccolallo, L. ;
Santaquilani, M. ;
Berrino, F. .
ANNALS OF ONCOLOGY, 2003, 14 :V128-V149
[6]
Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997) [J].
Colonna, M ;
Grosclaude, P ;
Remontet, L ;
Schvartz, C ;
Mace-Lesech, J ;
Velten, M ;
Guizard, AV ;
Tretarre, B ;
Buemi, A ;
Arveux, P ;
Esteve, J .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (13) :1762-1768
[7]
Standard cancer patient population for age standardising survival ratios [J].
Corazziari, I ;
Quinn, M ;
Capocaccia, R .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (15) :2307-2316
[8]
De Angelis R, 1999, STAT MED, V18, P441, DOI 10.1002/(SICI)1097-0258(19990228)18:4<441::AID-SIM23>3.3.CO
[9]
2-D
[10]
Regression models for relative survival [J].
Dickman, PW ;
Sloggett, A ;
Hills, M ;
Hakulinen, T .
STATISTICS IN MEDICINE, 2004, 23 (01) :51-64